Literature DB >> 31979231

Antibacterial Polyketides from Antarctica Sponge-Derived Fungus Penicillium sp. HDN151272.

Mudassir Shah1, Chunxiao Sun1, Zichao Sun1, Guojian Zhang1,2, Qian Che1, Qianqun Gu1, Tianjiao Zhu1, Dehai Li1,2,3.   

Abstract

Three new polyketides, ketidocillinones A-C (1-3), were discovered from the extract of an Antarctica sponge-derived fungus Penicillium sp. HDN151272. All the structures were deduced by spectroscopic data, including NMR and HRESIMS. The absolute configuration of compound 3 was established by using ECD calculation. Compounds 1-3 can be slowly oxidized to quinone form when exposed to air. Ketidocillinones B and C (2 and 3) exhibited potent antibacterial activity against Pseudomonas aeurigenosa, Mycobacterium phlei, and MRCNS (methicillin-resistant coagulase-negative staphylococci) with MIC values ranging from 1.56 to 25.00 µg/mL.

Entities:  

Keywords:  Antarctica sponge-derived fungus; Penicillium sp.; antibacterial activity; polyketides

Year:  2020        PMID: 31979231      PMCID: PMC7073682          DOI: 10.3390/md18020071

Source DB:  PubMed          Journal:  Mar Drugs        ISSN: 1660-3397            Impact factor:   5.118


1. Introduction

Microorganisms that belong to distinctive ecosystems, such as Polar Regions, have productive sources of different chemical skeletons and unusual natural products along with versatile and unparalleled biological potentials [1]. Polar regions, including the arctic, the Antarctic, and other related subregions, are considered the most inaccessible and arduous domain on the planet. To continue existence and endurance under the persistent influence of natural stressors, such as extremely low temperature, deficient of nutritional substrates, lack of metabolite transfers, UV (ultra violet-radiation) and interim concentrated heat during the Antarctic summer, the Antarctica associated microorganisms need a different range of bio-physiological adaptations which are necessary for existence [1,2]. These adaptations are frequently convoyed by manipulations to both gene regulation and metabolic pathways, in turn enlarging the opportunity to search for innovative functional metabolites with pharmaceutical potential [1,3]. The Antarctic-derived microorganisms would have the opportunity to produce novel metabolites with unusual and exclusive structures along with attractive biological activities [4,5,6,7]. During our efforts to explore new bioactive molecules from Antarctica sponge-derived microorganisms [8,9,10], a fungal strain Penicillium sp. HDN151272, isolated from an unidentified sponge sample collected in the Prydz Bay, was selected for chemical investigation due to its interesting HPLC-UV profile. A chemical investigation of the organic extract of the fungus led to the discovery of three hydroquinone polyketides (Figure 1), namely ketidocillinones AC (1−3), which displayed different side chains compared with the previously reported hydroquinone polyketides [11,12]. Compounds 2 and 3 exhibited broad-spectrum antibacterial activity. Herein, we report the details of the isolation, structure elucidation, absolute configuration, and biological activities of the new compounds.
Figure 1

Structures of compounds 1–3.

2. Results and Discussion

The fungal strain Penicillium sp. HDN151272 was cultured at 28 °C for 9 days under shaking condition. The extract (10 g) of the fermentation (30 L) was fractionated by ODS and LH-20 column chromatography and HPLC using ODS, producing compounds 1 (7.0 mg), 2 (6.0 mg), 3 (5.5 mg). Compound 1 was isolated as a deep yellowish powder, and the HRESIMS ion detected at m/z 249.1134 [M − H]− indicated a molecular formula of C14H18O4, accounting for six degrees of unsaturation. 1H NMR data (Table 1) displayed resonances for two methyls (δH 1.60, s, H3-14; 1.97, s, H3-15), three methylenes (δH 2.48, m, H2-7; 2.12, m, H2-8; 2.93, d, H2-11), three olefinic protons (δH 6.44, s, H-3; 6.44, H-6; 5.26, t, H-10), and two phenolic hydroxyls (δH 8.34, s, 1-OH; 8.30, s, 4-OH). The 13C NMR as well as DEPT and HSQC spectrum data in dicated 14 carbon resonances assignable to two sp3 methyls (δC 16.7, C-14; 16.2, C-15), three sp3 methylenes (δC 28.7, C-7; 39.9, C-8; 33.7, C-11), three sp2 methines (δC 116.2, C-3; 117.5, C-6; 116.8, C-10), and six quaternary carbons (δC 147.5, C-1; 126.0, C-2; 147.9, C-4; 121.7, C-5; 138.2, C-9; 173.5, C-12). Careful analysis of the 13C NMR data of 1 revealed a hydroquinone-type skeleton, which was further verified by the HMBC correlations (Figure 2). Detailed analysis of the COSY spectrum revealed spin systems, including H-7/H-8 and H-10/H-11 (Figure 2). The presence of side chain C-7/C-8/C-9(C-15)/C-10/C-11/C-12 was supported by the HMBC correlations from H-15 to C-8, C-9, and C-10, and from H-11 to C-9, C-10 and C-12. Further HMBC cross peaks from H-7 to C-2 and C-3 and from H-8 to C-2 attached the side chain to C-2. The E geometry of the double bond between C-9 and C-10 was inferred based on the NOESY correlations from H-15 to H-11 and from H-10 to H-8. Accordingly, the structure of 1 was established as shown and named as ketidocillinone A.
Table 1

1H (500 MHz, J in Hz) NMR and 13C (125 MHz) NMR data for compounds 1−3 in DMSO-d6.

No.123
1H13C (Type)1H13C (Type)1H13C (Type)
1 147.5, C 147.5, C 147.5, C
2 126.0, C 125.9, C 125.4, C
36.44, s116.2, CH6.44, s117.4, CH6.41, s116.2, CH
4 147.9, C 147.9, C 147.9, C
5 121.7, C 121.8, C 121.9, C
66.44, s117.5, CH6.43, s116.3, CH6.44, s117.5, CH
72.48, m28.7, CH22.46, m28.6, CH22.36, ov.27.3, CH2
82.12, m39.9, CH22.13, t (8.5)39.8, CH21.53, m33.9, CH2
1.75, m
9 138.2, C 138.9, C2.36, ov.38.6, CH
105.26, t (7.2)116.8, CH5.24, m116.1, CH 176.7, C
112.93, d (7.1)33.7, CH23.03, d (7.1)33.3, CH23.58, s51.7, CH3
12 173.5, C 172.4, C1.97, s16.2, CH3
13 3.57, s51.8, CH31.08, s17.2, CH3
141.60, s16.7, CH31.61, s16.7, CH3
151.97, s ov.16.2,CH31.97, s16.2, CH3
1-OH8.34, s 8.35, s 8.35, s
4-OH8.30, s 8.31, s 8.33, s
Figure 2

Key COSY and HMBC correlations of 1.

Compound 2 was isolated as a deep yellowish powder. The HRESIMS peak at m/z 263.1289 [M − H]− indicated a molecular formula of C15H20O4, with 14 mass units more than 1. The 1D NMR data (Table 1) indicated one extra oxygenated methyl group in the structure than 1. The observed HMBC (Figure 3) correlation from H-13 to C-12 confirmed that compound 2 was a methyl ester of 1. The geometrical configuration of the double bond between C-9 and C-10 was inferred to be E based on the NOESY correlations from H-15 to H-11 and from H-10 to H-8. Thus, the structure of 2 was fully established, as shown and named as ketidocillinone B.
Figure 3

Key COSY and HMBC correlations of compounds 2–3.

Compound 3, isolated as a light yellowish powder, was deduced to have a molecular formula of C13H18O4 by HRESIMS. Analysis of the 1H and 13C NMR (Table 1), as well as the HSQC data of 3, revealed the presence of three methyls including an oxygenated (δC 51.7, C-11), two methylenes (δC 27.3, C-7; 33.9, C-8), three methines (δC 116.2, C-3; 117.5, C-6; 38.6, C-9), and five nonprotonated sp2 carbons (δC 147.5, C-1; 125.4, C-2; 147.9, C-4; 121.9, C-5; 176.7, C-10). The almost identical UV spectra of 1–3 suggested they share the same aromatic chromophore, which was further confirmed by the HMBC correlations (Figure 3). The MS and 1D NMR data revealed a shortened side chain in 3, which was confirmed by COSY correlations of H-7/H-8/H-9/H-13 and HMBC correlations from H-7 to C-9, from H-8 to C-10 and C-13, from H-13 to C-8 and C-10, from H-11 to C-10 (Figure 3). Further HMBC cross peaks from H-7 to C-2 and C-3 and from H-8 to C-2 attached the side chain to C-2. Consequently, the planar structure of 3 was established as shown and named as ketidocillinone C. The absolute configuration of C-9 in compound 3 was deduced by the calculated ECD spectra. The theoretical calculated electronic circular dichroism spectra were performed using TDDFT (time-dependent density functional theory). The optimized conformation of the model was obtained and further used for the ECD calculation at the B3LYP/6-31G (+d) level. The overall pattern of the experimental ECD spectrum was in reasonable agreement with the calculated ECD spectra (Figure 4). Thus, the absolute configuration of 3 was established as 9S.
Figure 4

Calculated and experimental ECD spectra of 3 in DMSO.

Dihydroquinones can sometimes be converted to quinones by oxidative transformation. For instance, the natural p-dihydroquinones [11], and fallahydroquinone [12], isolated from the Western Australian brown alga Cystophora sp., and the southern Australian brown alga Sargassum fallax, respectively, were discovered to be the results of rapid air mediated oxidation on the (2′E)-2-(3′,7′-dimethylocta-2′,6′-dienyl)-6-methyl-2,5-cyclohexadiene-1,4-dione moiety. With regard to compounds ketidocillinones AC, after exposure to air for about one week, these pure compounds were transformed into mixtures of both enol/keto form structures (Figure 5) with the ratios (enol:keto) 1:1 for 1 (Figure S32), 2:1 for 2 (Figure S39), and 5:4 for 3 (Figure S46), which again proved the non-enzymatic oxidation transformation from dihydroquinones to quinones in natural products. To classify the results, we also collected the NMR data of the mixture of enol/keto forms of 1–3 (Table 2 and Table 3, Figures S32–S51).
Figure 5

Oxidative transformation of 1–3.

Table 2

1H (500 MHz, J in Hz) NMR data for compounds 1–3 in CDCl3.

No.123
ababab
36.53, ov.6.53, ov.6.55, ov.6.55, ov.6.55, s6.52, s
66.53, ov.6.53, ov.6.55, ov.6.55, ov.6.59, s6.62, s
72.51, t (7.5)2.62, m2.53, t (7.4)2.65, t (7.5)2.42, m2.52, ov.
82.20, t (7.5)2.26, t (7.8)2.23, t (7.4)2.28, t (7.5)1.88, ov.1.89, ov.
1.62, m1.71, m
9 2.51, ov.2.51, ov.
105.32, ov.5.28, ov.5.32, t (6.4)5.28,t (6.9)
113.02, ov.3.02, ov.3.04, ov.3.04, ov.3.68, s3.72, s
12 2.04, s2.17, s
13 3.67, s3.68, s1.19, ov.1.20, ov.
142.00, s2.12, s2.03, s2.16, s
151.64, s1.65, s1.66, s1.68, s

ov. Overlapped signals.

Table 3

13C (125 MHz) NMR data for compounds 1–3 in CDCl3.

No.1 (Type)2 (Type)3 (Type)
a babab
1147.6, C185.9, C146.9, C187.6, C147.7, C187.5, C
2127.0, C148.8, C126.7, C148.7, C125.6, C148.6, C
3117.6, CH132.9, CH116.7, CH132.8, CH116.3, CH132.7, CH
4147.7, C187.7, C147.6, C188.1, C147.3, C188.1, C
5122.1, C145.6, C122.2, C145.6, C122.7, C145.7, C
6118.0, CH133.6, CH118.0, CH133.5, CH118.3, CH133.6, CH
729.8, CH227.2, CH227.9, CH227.1, CH227.6, CH226.5, CH2
839.8, CH237.7, CH239.7, CH237.6, CH234.0, CH231.5, CH2
9138.2, C137.3, C139.2, C137.3, C38.7, CH39.0, CH
10116.9, CH118.0, CH116.3, CH117.2, CH177.9, C176.5, C
1133.6, CH233.4, CH233.5, CH233.5, CH252.0, CH351.7, CH3
12173.7, C171.9, C173.2, C172.5, C15.5, CH315.5, CH3
13 51.9, CH351.8, CH317.3, CH317.1, CH3
1415.5, CH315.7, CH315.4, CH315.5, CH3
1516.7, CH316.3, CH316.5, CH316.2, CH3
All the compounds were tested for antimicrobial activity. Compound 2 (a mixture of 2a and 2b) exhibited inhibitory activity against Mycobactrium phlei, Pseudomonas aeruginosa, MRCNS and Bacillus cereus with MIC ranging from 1.56 to 12.50 µg/mL, respectively, while compound 1 (mixture of 1a and 1b) was inactive (MIC > 50 µg/mL), which indicated that the methoxy group played a crucial role for the activity. Compound 3 (a mixture of 3a and 3b) also showed antibacterial activity against MRCNS, Mycobactrium phlei, Pseudomonas aeruginosa, Vibrio parahemolyticus, and Bacillus subtilis with MIC ranging from 6.25 to 25.00 µg/mL (Table 4).
Table 4

Antibacterial activity for compounds 1–3 (mixtures of the phenol and quinone products) (MIC, µg/mL).

Compd. V. Parahemolyticus E. coli Prot - eus sp. B. subtilis MRCNS B. cereus P. aeruginosa M. Phlei M. albican
1 >50>50>50>50>50>50>50>50>50
2 >50>50>50>506.2512.501.563.13>50
3 12.50>50>5012.506.2525.006.256.25>50
Ciprofloxacin0.522.070.520.980.980.980.983.913.91

3. Materials and Methods

3.1. General Experimental Procedures

Optical rotations were recorded on a JASCO P-1020 (JASCO Corporation, Tokyo, Japan) digital polarimeter. UV spectra were obtained on HITACHI Chromaster 5430 (HITACHI Corporation, Tokyo, Japan), while the ECD spectra were obtained on JASCO J-815 spectropolarimeter (JASCO Corporation, Tokyo, Japan). 1H NMR, 13C NMR, DEPT, and 2D NMR spectra were recorded on an Agilent 500 MHz DD2 spectrometer (Agilent Technologies Inc., Santa Clara, CA, USA). HRESIMS spectra were obtained using a Thermo Scientific LTQ Orbitrap XL mass spectrometer (Thermo Fisher Scientific, Waltham, MA, USA). Column chromatography (CC) was achieved with silica gel (200–300 mesh, Qingdao Marine Chemical Inc., Qingdao, China) and Sephadex LH-20 (Amersham Biosciences, San Francisco, CA, USA). MPLC was done on a Bona-Agela CHEETAHTM HP100 (Beijing Agela Technologies Co., Ltd., Beijing, China). RP-HPLC was accomplished on an ODS column (HPLC (YMC-Pack ODS-A, 10 × 250 mm, 5 µm, 3 mL/min)) (YMC Co., Ltd., Kyoto, Japan).

3.2. Fungal Material

The fungal strain Penicillium sp. HDN151272 was isolated from a sample of an Antarctic associated marine sponge collected at Prydz Bay (depth 410 m, E 67.6°, S 66.1°, collected in mid-April 2016). The sponge was not identified due to the limited sample. Genetically, the fungal species was recognized by its morphological characteristics and ITS sequence of the rRNA gene. The sequence is available at GenBank with the accession number MN788660. The strain is deposited at the Key Laboratory of Marine Drugs, the Ministry of Education of China, Qingdao, People’s Republic of China.

3.3. Fermentation

The fungal strain Penicillium sp. HDN151272 was cultured and activated on PDA (potato dextrose agar) slants at 28 °C for 3 days. After activation of the strain, fermentation was achieved in Erlenmeyer flasks (500 mL) containing 150 mL of liquid culture medium, composed of glucose (1%), maltose (2%), mannitol (2%), monosodium glutamate (1%), KH2PO4 (0.05%), MgSO4·7H2O (0.03%), corn steep liquor (0.1%), and yeast extract (0.3%). The liquid culture medium was prepared by adding naturally collected seawater from Jiaozhou Bay, Qingdao, China, and adjusting the pH to 6.5. All the contents were subjected to autoclaving at 121 °C for 20 min. After autoclaving and cooling to 25 °C, each flask was inoculated with fungal spores and subjected to incubation at 28 °C for 9 days in shaking conditions.

3.4. Extraction and Purification

The whole fermentation broth (30 L) was filtered through a muslin cloth to separate the supernatant from the mycelia. The supernatant was extracted three times by using EtOAc (3 × 30 L), and the mycelia were homogenized and extracted three times by using MeOH (3 × 10 L). The supernatant and mycelia extracts were combined and dried in vacuo. The extract (10.0 g) was separated by VLC (vacuum liquid chromatography) on silica gel via a stepped gradient elution DCM-MeOH (100:0 to 0:100) to give twelve fractions (Fr.1 to Fr.12). Fr.5 was further separated by MPLC (C-18 ODS) using a stepped gradient elution of MeOH-H2O (5:95 to 100:0) to yield 11 subfractions (Fr.5-1 to Fr.5-11). Fr.5-5, Fr.5-6, and Fr.5-7 were further separated on a Sephadex LH-20 column with MeOH to provide five subfractions (Fr.5-5-1 to Fr.5-5-5), five fractions (Fr.5-6-1 to Fr.5-6-5), and four fractions (Fr.5-7-1 to Fr.5-7-4), respectively. Fr.5-5-3, Fr.5-6-4, and Fr.5-7-3 were separated by semi-preparative HPLC eluted with MeOH-H2O (64:36) to obtain compound 1 (7.0 mg, tR = 33.3 min), MeOH-H2O (43:57) to obtain compound 2 (6.0 mg, tR = 38.2 min), MeOH-H2O (40:60) to obtain 3 (5.5 mg, tR = 31.8 min), respectively. Ketidocillinone A (1). deep yellowish powder; UV (MeCN) λmax (log ε): 241 (3.16) nm; IR (KBr) νmax 3276, 2929, 1698, 1653, 1203, 1139, 1026, 801, 723 cm−1; 1H and 13C NMR data see Table 1 and Table 2; HRESIMS m/z 247.0981 [M − H]− (calcd. for C14H15O4, 247.0976), m/z 249.1134 [M − H]− (calcd. for C14H17O4, 247.1132). Ketidocillinone B (2). deep yellowish powder; UV (MeCN) λmax (log ε): 241 (3.32) nm; IR (KBr) νmax 3355, 2922, 2378, 1698, 1498, 1208, 1136, 1030, 840, 802, 723 cm−1; 1H and 13C NMR data see Table 1 and Table 2; HRESIMS m/z 261.1129 [M − H]− (calcd. for C15H17O4, 261.1132), m/z 263.1289 [M − H]− (calcd. for C15H19O4, 263.1289). Ketidocillinone C (3). light yellowish powder; +4.56 (c 0.03, MeOH); UV (MeCN) λmax (log ε): 242 (2.56) nm; IR (KBr) νmax 3338, 2929, 2358, 1717, 1698, 1457, 1205, 1142, 1027, 874, 801, 722, 518 cm−1; ECD (2.5 mM, MeOH) λmax (Δε) 210 (+4.24), 242 (−4.56), 342 (+5.25) nm; 1H and 13C NMR data see Table 1 and Table 2; HRESIMS m/z 235.0975 [M − H]− (calcd. for C13H15O4, 235.0976), m/z 237.1131 [M − H]− (calcd. for C13H17O4, 237.1132).

3.5. Assay of Antimicrobial Activity

Antimicrobial activity was determined by the broth microdilution method [13] against eight types of bacterial strains such as MRCNS, Vibrio parahemolyticus, Escherichia coli, Proteus species, Bacillus subtilis, Bacillus cereus, Mycobacterium phlei, Pseudomonas aeruginosa, and one fungus Monilia albican and were used in the antimicrobial assay. All experiments were performed in triplicates, and ciprofloxacin (J&K Chemical Technology, Beijing, China) was used as a positive control. All strains were donated by Qingdao municipal hospital and deposited at the Key Laboratory of Marine Drugs, the Ministry of Education of China, Qingdao, People’s Republic of China.

3.6. Computation Section

Conformational searches were run employing the “systematic” procedure implemented in Spartan 14 [14], using MMFF (merck molecular force field). All MMFF minima were reoptimized with DFT calculations at the B3LYP/6-31+G(d) level using the Gaussian09 program [15]. The geometry was optimized, starting from various initial conformations, with vibrational frequency calculations confirming the presence of minima. TDDFT (time-dependent DFT) calculations were performed on the six lowest-energy conformations for 3 (>5% population) for each configuration using 20 excited states and using a PCM (polarizable continuum model) for MeOH. ECD spectra were generated using the program SpecDis [16] by applying a Gaussian band shape with 0.15 eV from dipole-length rotational strengths. The dipole velocity forms yielded negligible differences. The spectra of the conformers were combined using Boltzmann weighting, with the lowest-energy conformations accounting for about 99% of the weights. The calculated spectrum was blue-shifted by 10 nm to facilitate comparison to the experimental data.

4. Conclusions

The prenylated quinones and hydroquinones are omnipresent in natural surroundings [17] and extensively isolated from marine sponges [18,19], marine algae [20,21,22], ascidians [23,24,25], and microbes [26,27]. They have been spotted to have a diverse range of bioactivities, including cytotoxic [27,28], antioxidant [21,28], and anti-inflammatory [25] activities, among which quinone and hydroquinone nucleus seemed to be the critical pharmacophore [28]. Three new hydroquinone derivatives, ketidocillinones AC (1−3), were obtained from the Antarctica-sponge derived fungus Penicillium sp. HDN151272. Compounds 2 and 3 exhibited broad-spectrum antibacterial activities, especially against MRCNS and Mycobacterium phlei, which provide potential candidates for antibacterial drug development.
  21 in total

1.  Anti-inflammatory and antimalarial meroterpenoids from the New Zealand ascidian Aplidium scabellum.

Authors:  Susanna T S Chan; A Norrie Pearce; Ana H Januario; Michael J Page; Marcel Kaiser; Rene J McLaughlin; Jacquie L Harper; Victoria L Webb; David Barker; Brent R Copp
Journal:  J Org Chem       Date:  2011-10-03       Impact factor: 4.354

2.  Penipyridones A-F, Pyridone Alkaloids from Penicillium funiculosum.

Authors:  Haibo Zhou; Liyuan Li; Chongming Wu; Tibor Kurtán; Attila Mándi; Yankai Liu; Qianqun Gu; Tianjiao Zhu; Peng Guo; Dehai Li
Journal:  J Nat Prod       Date:  2016-06-30       Impact factor: 4.050

3.  A radical scavenging farnesylhydroquinone from a marine-derived fungus Penicillium sp.

Authors:  Byeng Wha Son; Jung Chul Kim; Hong Dae Choi; Jung Sook Kang
Journal:  Arch Pharm Res       Date:  2002-02       Impact factor: 4.946

4.  Secondary metabolites from Antarctic marine-derived fungus Penicillium crustosum HDN153086.

Authors:  Cong-Cong Liu; Zhen-Zhen Zhang; Yan-Yan Feng; Qian-Qun Gu; De-Hai Li; Tian-Jiao Zhu
Journal:  Nat Prod Res       Date:  2018-03-30       Impact factor: 2.861

5.  Antiviral Merosesquiterpenoids Produced by the Antarctic Fungus Aspergillus ochraceopetaliformis SCSIO 05702.

Authors:  Junfeng Wang; Xiaoyi Wei; Xiaochu Qin; Xinpeng Tian; Li Liao; Kemin Li; Xuefeng Zhou; Xianwen Yang; Fazuo Wang; Tianyu Zhang; Zhengchao Tu; Bo Chen; Yonghong Liu
Journal:  J Nat Prod       Date:  2015-12-23       Impact factor: 4.050

6.  Tetraprenyltoluquinols from the brown alga Cystophora fibrosa.

Authors:  Damian W Laird; Ian A van Altena
Journal:  Phytochemistry       Date:  2006-05-05       Impact factor: 4.072

Review 7.  Antitumour quinones.

Authors:  C Asche
Journal:  Mini Rev Med Chem       Date:  2005-05       Impact factor: 3.862

8.  Rossinones A and B, biologically active meroterpenoids from the Antarctic ascidian, Aplidium species.

Authors:  David R Appleton; Cheah Shiau Chuen; Michael V Berridge; Victoria L Webb; Brent R Copp
Journal:  J Org Chem       Date:  2009-12-04       Impact factor: 4.354

9.  New polyoxygenated farnesylcyclohexenones, deacetoxyyanuthone A and its hydro derivative from the marine-derived fungus Penicillium sp.

Authors:  Xifeng Li; Hong Dae Choi; Jung Sook Kang; Chong-O Lee; Byeng Wha Son
Journal:  J Nat Prod       Date:  2003-11       Impact factor: 4.050

Review 10.  Secondary Metabolites from Polar Organisms.

Authors:  Yuan Tian; Yan-Ling Li; Feng-Chun Zhao
Journal:  Mar Drugs       Date:  2017-02-23       Impact factor: 5.118

View more
  6 in total

1.  Bioactivity-Guided Screening of Antimicrobial Secondary Metabolites from Antarctic Cultivable Fungus Acrostalagmus luteoalbus CH-6 Combined with Molecular Networking.

Authors:  Ting Shi; Xiang-Qian Li; Ze-Min Wang; Li Zheng; Yan-Yan Yu; Jia-Jia Dai; Da-Yong Shi
Journal:  Mar Drugs       Date:  2022-05-19       Impact factor: 6.085

2.  Cytotoxic Secondary Metabolites Isolated from the Marine Alga-Associated Fungus Penicillium chrysogenum LD-201810.

Authors:  Lin-Lin Jiang; Jin-Xiu Tang; Yong-Heng Bo; You-Zhi Li; Tao Feng; Hong-Wei Zhu; Xin Yu; Xing-Xiao Zhang; Jian-Long Zhang; Weiyi Wang
Journal:  Mar Drugs       Date:  2020-05-22       Impact factor: 5.118

3.  Apoptotic Activity of New Oxisterigmatocystin Derivatives from the Marine-Derived Fungus Aspergillus nomius NC06.

Authors:  Muh Ade Artasasta; Yanwirasti Yanwirasti; Muhammad Taher; Akmal Djamaan; Ni Putu Ariantari; Ru Angelie Edrada-Ebel; Dian Handayani
Journal:  Mar Drugs       Date:  2021-11-11       Impact factor: 5.118

4.  Fungal Community Investigation from Propolis Natural Products: Diversity and Antibacterial Activities Evaluation.

Authors:  Souhir Sallemi; Abdelmalek Lekired; Nedra Korbi; Ilhem Saadouli; Ameur Cherif; Ines Zidi; Naouel Klibi; Hadda-Imene Ouzari; Amor Mosbah
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-16       Impact factor: 2.650

5.  Antibacterial Cyclic Tripeptides from Antarctica-Sponge-Derived Fungus Aspergillus insulicola HDN151418.

Authors:  Chunxiao Sun; Ziping Zhang; Zilin Ren; Liu Yu; Huan Zhou; Yaxin Han; Mudassir Shah; Qian Che; Guojian Zhang; Dehai Li; Tianjiao Zhu
Journal:  Mar Drugs       Date:  2020-10-26       Impact factor: 5.118

Review 6.  Discovery of Marine Natural Products as Promising Antibiotics against Pseudomonas aeruginosa.

Authors:  Haoran Li; Mireguli Maimaitiming; Yue Zhou; Huaxuan Li; Pingyuan Wang; Yang Liu; Till F Schäberle; Zhiqing Liu; Chang-Yun Wang
Journal:  Mar Drugs       Date:  2022-03-04       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.